About
Blood Test for Colon Cancer
Areas of Focus
Categories
DiagnosticsBiotech
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
2,460
By Status
UNKNOWN: 4
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details
Recent Trials
NCT05127096Lead Sponsor
Sample Collection Study for the CellMax Life Circulating Tumor Cell and Circulating Tumor DNA Platforms for the Early Detection of Colorectal Cancer and Adenomas
N/AUnknown
1,000 participants
Started: Dec 15, 2020 · Completed: Dec 30, 2022
NCT03476122Lead Sponsor
Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer
N/AUnknown
750 participants
Started: Mar 15, 2018 · Completed: Mar 13, 2021
NCT03488706Lead Sponsor
Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level
N/AUnknown
500 participants
Started: Jan 17, 2018 · Completed: Jun 2, 2021
NCT03511859Lead Sponsor
Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics
N/AUnknown
210 participants
Started: Nov 16, 2017 · Completed: Dec 31, 2019
Locations (1)
Headquarters
Sunnyvale, CA, United States
Map
Loading map...